In the second biomarker discovery study to detect a biomarker panel to monitor bladder cancer patients in follow-up, only HBB and HBA1 were identified as statistically significant biomarkers with an absolute fold change larger than 0.6 and an FDR-corrected p value smaller than 0.05. This evidence concerns the gene HBA1 and urinary bladder carcinoma.